Alkeus Pharmaceuticals’ $150 Million Series B Financing Round

Foley & Lardner LLP represented TCGX as co-lead investor. Alkeus Pharmaceuticals closed its $150 million Series B financing for Alkeus Pharmaceuticals. TCGX was joined by Bain…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

This content is for Standard 1 Year members only.
Login Join Now